Atlas Trials

Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis

Clinical trial NCT00404092 · COMPLETED

Trial details

NCT number
NCT00404092
Sponsor
University of Cologne
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Invasive Aspergillosis
Start date
2006-10-01
Primary completion
2009-10-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.